Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Observational Study in Italy

INTRODUCTION: Type 2 diabetes mellitus (T2DM) is a relevant risk factor for severe forms of COVID-19 (SARS coronavrus 2 [SARS-CoV-2] disease 2019), and calls for caution because of the high prevalence of T2DM worldwide and the high mortality rates observed in patients with T2DM who are infected with...

Descripción completa

Detalles Bibliográficos
Autores principales: Monda, Vincenzo M., Voci, Claudio, Strollo, Felice, Passaro, Angelina, Greco, Salvatore, Monesi, Marcello, Bigoni, Renato, Porcellati, Francesca, Piani, Daniela, Satta, Ersilia, Gentile, Sandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597965/
https://www.ncbi.nlm.nih.gov/pubmed/37801224
http://dx.doi.org/10.1007/s13300-023-01472-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597965/
https://www.ncbi.nlm.nih.gov/pubmed/37801224
http://dx.doi.org/10.1007/s13300-023-01472-8

Ejemplares similares